imipramine has been researched along with Autoimmune Diseases in 2 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
Autoimmune Diseases: Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Staines, DR | 1 |
| Moeschlin, S | 1 |
2 other studies available for imipramine and Autoimmune Diseases
| Article | Year |
|---|---|
Phosphodiesterase inhibitors may be indicated in the treatment of postulated vasoactive neuropeptide autoimmune fatigue-related disorders.
Topics: Autoimmune Diseases; Cyclic AMP; Fatigue Syndrome, Chronic; Humans; Imipramine; Neuropeptides; Phosp | 2006 |
[Exogenous and endogenous (hyperparathyroidism, Wegener's granulomatosis) poisonings].
Topics: Adenoma; Adult; Aged; Arsenic Poisoning; Autoimmune Diseases; Azathioprine; Child, Preschool; Diagno | 1967 |